Omeros (OMER) Interest & Investment Income (2010 - 2026)

Omeros (OMER) reported Interest & Investment Income of $1.5 million for Q1 2026, up 31.34% on a YoY basis from $1.1 million in Q1 2025, and up 32.05% sequentially from $1.1 million in Q4 2025.

Omeros (OMER) Interest & Investment Income (2010 - 2026) Analysis & Trends

Omeros (OMER) has 11 years of Interest & Investment Income data on file, last reported at $1.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Interest & Investment Income rose 31.34% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $4.4 million (down 50.53% YoY), and the FY2025 full-year result was $4.1 million, down 63.7% from the prior year.
  • Interest & Investment Income improved to $1.5 million in Q1 2026, from $1.1 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $4.5 million in Q2 2023 to a low of $493000.0 in Q1 2022.
  • A 5-year average of $2.2 million and a median of $2.0 million in 2022 frame the typical range for Interest & Investment Income.
  • Across the five-year window, Interest & Investment Income soared 703.85% in 2023 and slumped 73.74% in 2025, its largest moves.
  • Tracing OMER's Interest & Investment Income over 5 years: stood at $2.0 million in 2022, then jumped by 72.05% to $3.4 million in 2023, then slumped by 33.6% to $2.3 million in 2024, then slumped by 50.94% to $1.1 million in 2025, then soared by 32.05% to $1.5 million in 2026.
  • Business Quant data shows OMER's Interest & Investment Income at $1.5 million in Q1 2026, $1.1 million in Q4 2025, and $616000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 27.66 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 114.80 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -65.80 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 44.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 19.51 Mn
10 Omeros 707.67 Mn 707.67 Mn 9.31 Mn 1.48 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.48 Mn
Dec 31, 2025 1.12 Mn
Sep 30, 2025 616,000.00
Jun 30, 2025 1.24 Mn
Mar 31, 2025 1.12 Mn
Dec 31, 2024 2.28 Mn
Sep 30, 2024 2.35 Mn
Jun 30, 2024 3.25 Mn
Mar 31, 2024 3.42 Mn
Dec 31, 2023 3.43 Mn
Sep 30, 2023 4.41 Mn
Jun 30, 2023 4.54 Mn
Mar 31, 2023 3.96 Mn
Dec 31, 2022 1.99 Mn
Sep 30, 2022 906,000.00
Jun 30, 2022 670,000.00
Mar 31, 2022 493,000.00
Dec 31, 2021 528,000.00
Sep 30, 2021 461,000.00
Dec 31, 2014 -205,000.00